Protara Therapeutics Inc. (TARA)
NASDAQ: TARA
· Real-Time Price · USD
3.03
-0.16 (-5.02%)
At close: Aug 15, 2025, 3:59 PM
3.09
1.98%
After-hours: Aug 15, 2025, 07:48 PM EDT
Protara Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -14.96M | -11.91M | -12.77M | -11.22M | -9.51M | -11.1M | -10.22M | -9.86M | -11.29M | -9.04M | -38.97M | -7.69M | -8.54M | -10.76M | -10.23M | -10.78M | -12.78M | -13.46M |
Depreciation & Amortization | -165K | 83K | 82K | 84K | 83K | 83K | 107K | 107K | 78K | 77K | -949K | 1.09M | 53K | 56K | 54K | -24K | 55K | 32K |
Stock-Based Compensation | 903K | 833K | 904K | 931K | 1.06M | 1.23M | 1.45M | 1.45M | 1.62M | 1.57M | 1.43M | 1.44M | 1.94M | 1.88M | 1.91M | 2.72M | 3M | 2.74M |
Other Working Capital | -1.18M | -2.31M | 975K | 937K | 23K | 691K | -157K | 1.22M | 2.21M | -2.5M | 1.34M | -518K | 1.22M | -2.14M | 876K | 1.83M | 240K | -2.45M |
Other Non-Cash Items | 164K | 97K | -20K | 1.44M | 243K | 178K | 1.93M | 882K | 342K | 270K | 30.99M | 273K | 346K | 410K | 457K | 533K | 464K | 283K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.74M | -1.01M | -133K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 1.81M | -3.81M | 2.5M | 335K | 436K | -771K | -227K | 1.87M | -19K | -5.76M | 2.47M | -454K | 1.07M | -2.55M | 902K | 1.35M | -209K | -1.51M |
Operating Cash Flow | -12.25M | -14.71M | -9.31M | -8.43M | -7.69M | -10.38M | -8.7M | -6.56M | -9.41M | -12.89M | -5.03M | -5.35M | -5.12M | -10.96M | -6.91M | -6.2M | -9.47M | -11.92M |
Capital Expenditures | -22K | -44K | n/a | -8K | -55K | n/a | n/a | -37K | -2K | -6K | -6K | -83K | -20K | -11K | -44K | 64K | -326K | -290K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9.87K | 18.34K | n/a | -13.52K | n/a | 16.43M | n/a | n/a | n/a |
Purchase of Investments | -51.7M | -65.81M | n/a | -29.38M | n/a | n/a | n/a | n/a | n/a | -12.19M | -29.12M | n/a | -2.01M | -12.41M | -8.79M | -16.39M | -1.61M | -97.96M |
Sales Maturities Of Investments | 4M | 7.5M | 22.5M | n/a | 3M | 23.1M | 14.52M | 6.42M | 22.35M | 22.05M | 10.78M | 19.13M | 15.54M | 13.17M | 10.72M | 16.43M | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 22.35K | 9.87K | -18.34K | 19.13K | 13.52K | 756K | -16.43M | 16.43M | -1.61M | -97.96M |
Investing Cash Flow | -47.72M | -58.35M | 22.5M | -29.39M | 2.94M | 23.1M | 14.52M | 6.38M | 22.35M | 9.86M | -18.34M | 19.05M | 13.5M | 745K | 1.89M | 107K | -1.94M | -98.25M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | -7K | -76K | 91K | -27K | n/a | -64K | 90K | -18K | n/a | -72K | 228K | n/a | n/a | -228K |
Dividend Paid | n/a | n/a | n/a | -11K | -11K | n/a | n/a | -2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | -185K | n/a | 11K | 63K | n/a | 4K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | -228K | n/a | n/a | n/a |
Financial Cash Flow | 8K | 1.73M | 97.85M | n/a | 42.09M | -76K | 4K | -27K | n/a | -64K | 72K | -18K | n/a | -72K | n/a | n/a | n/a | -228K |
Net Cash Flow | -59.97M | -71.34M | 111.04M | -37.82M | 37.35M | 12.64M | 5.82M | -210K | 12.94M | -3.09M | -23.37M | 13.68M | 8.38M | -10.29M | -5.02M | -6.09M | -11.41M | -110.4M |
Free Cash Flow | -12.27M | -14.76M | -9.31M | -8.44M | -7.74M | -10.38M | -8.7M | -6.6M | -9.41M | -12.89M | -5.03M | -5.43M | -5.14M | -10.97M | -6.95M | -6.14M | -9.8M | -12.21M |